Oxbryta (Voxelotor): Uses, Side Effects & Interactions
Oxbryta is a targeted oral therapeutic agent utilizing voxelotor to actively modulate the oxygen affinity of hemoglobin in patients with sickle cell disease. By reversibly binding to hemoglobin, it stabilizes the oxygenated state to inhibit red blood cell polymerization. It is highly critical to note that Oxbryta was globally withdrawn from all markets in September … Read more